Virtus Investment Advisers’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$101K Sell
2,136
-914
-30% -$43.1K 0.03% 330
2025
Q1
$119K Buy
+3,050
New +$119K 0.03% 393